Tesaglitazar AstraZeneca
Davis, T.
Idrugs the Investigational Drugs Journal 5(9): 924-926
2002
ISSN/ISBN: 1369-7056 PMID: 12800054 Document Number: 545403
AstraZeneca (formerly Astra) is developing tesaglitazar, a peroxisome proliferator-activated receptor (PPAR) agonist, for the potential treatment of diabetes and insulin resistance [275466], [377656]. Early phase clinical trials for both of these indications were ongoing in July 2002 [459440].